Lemaitre Vascular (LMAT) 15.03 $LMAT Haemonetics: Q4 Hit

New Post Public Reply Private Reply Replies (0) Message Board

Jun 11, 2016 at 10:07 PM

Lemaitre Vascular (LMAT) 15.03 $LMAT

Haemonetics: Q4 Hit by Issues in Russia, Currency Woes Stay
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 8:51AM CDT
Haemonetics (HAE) posted a dismal fourth-quarter fiscal 2016 with both EPS and revenues failing to meet the Zacks Consensus Estimate.
BSX: 23.02 (-0.30), HAE: 29.58 (-0.14), BAX: 44.49 (-0.26), LMAT: 15.03 (-0.06)

Hill-Rom: Welch-Allyn Buyout Drives Q2, Forex Woes Stay
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 9:20AM CDT
Hill-Rom (HRC) posted a mixed second quarter of fiscal 2016 with the bottom line surpassing the Zacks Consensus Estimate and the top line missing the same.
BSX: 23.02 (-0.30), BAX: 44.49 (-0.26), LMAT: 15.03 (-0.06), HRC: 50.10 (-1.12)

Hologic: Q2 Strong on Segmental Expansion, Competition Rife
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:43AM CDT
Hologic (HOLX) ended second-quarter fiscal 2016 on a promising note, squarely beating the Zacks Consensus Estimate.
BSX: 23.02 (-0.30), BAX: 44.49 (-0.26), LMAT: 15.03 (-0.06), HOLX: 34.14 (-0.81)

Mead Johnson: Strong Q1 on Overseas Growth & Strategies
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 6:40AM CDT
Mead Johnson (MJN) embarked on a promising journey this year, posting square beats in the first quarter.
BSX: 23.02 (-0.30), MJN: 83.79 (-0.38), BAX: 44.49 (-0.26), LMAT: 15.03 (-0.06)

Abaxis (ABAX): Solid Veterinary Show Despite Global Hiccups
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:01AM CDT
On Jun 3, 2016, we issued an updated research report on Abaxis, Inc. (ABAX). The stock currently carries a Zacks Rank #4 (Sell).
ICUI: 107.33 (-0.80), ABAX: 45.53 (-1.36), LMAT: 15.03 (-0.06), NUVA: 58.98 (-1.03)

Henry Schein: Q1 Results Strong, Expansion Plans on Track
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 8:02AM CDT
Henry Schein (HSIC)made an impressive start to 2016, with its top and bottom line beating the Zacks Consensus Estimate in the first quarter.
BSX: 23.02 (-0.30), BAX: 44.49 (-0.26), LMAT: 15.03 (-0.06), HSIC: 178.35 (-2.36)

Medtronic (MDT) Posts Solid Q4; Covidien Synergy Continues
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 6:31AM CDT
On Jun 3, 2016, we issued an updated research report on Medtronic plc (MDT).
BSX: 23.02 (-0.30), ICUI: 107.33 (-0.80), MDT: 85.70 (-0.08), LMAT: 15.03 (-0.06)

Medtronic (MDT) Beats Q4 Earnings & Revenue Estimates
Zacks Equity Research - Zacks Investment Research - Tue May 31, 8:01AM CDT
Medtronic's (MDT) fourth-quarter fiscal 2016 adjusted earnings per share (EPS) came in at $1.27, a penny ahead of the Zacks Consensus Estimate.
BSX: 23.02 (-0.30), ICUI: 107.33 (-0.80), MDT: 85.70 (-0.08), LMAT: 15.03 (-0.06)

NuVasive Poised on Solid International Sales, Scope in Spine
Zacks Equity Research - Zacks Investment Research - Tue May 31, 6:01AM CDT
On May 30, 2016, we updated our research report on NuVasive, Inc. (NUVA).
BSX: 23.02 (-0.30), ICUI: 107.33 (-0.80), LMAT: 15.03 (-0.06), NUVA: 58.98 (-1.03)

Medtronic (MDT): Will Currency Woes Hurt Q4 As Well?
Zacks Equity Research - Zacks Investment Research - Fri May 27, 6:26AM CDT
On May 26, 2016, we issued an updated research report on Medtronic plc (MDT).
BSX: 23.02 (-0.30), ICUI: 107.33 (-0.80), MDT: 85.70 (-0.08), LMAT: 15.03 (-0.06)

Abaxis (ABAX) Posts Solid Q4 amid International Headwind
Zacks Equity Research - Zacks Investment Research - Wed May 25, 5:28AM CDT
On May 18, 2016, we issued an updated research report on Abaxis, Inc. (ABAX).
ICUI: 107.33 (-0.80), ABAX: 45.53 (-1.36), LMAT: 15.03 (-0.06), NUVA: 58.98 (-1.03)

Genomic Health (GHDX): Q1 Results Strong, Costs Escalate
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:25AM CDT
Genomic Health (GHDX) has had a satisfactory run so far this year with its first-quarter earnings improving year over year and the top line surpassing the Zacks Consensus Estimate.
BSX: 23.02 (-0.30), BAX: 44.49 (-0.26), LMAT: 15.03 (-0.06), GHDX: 26.18 (-0.02)

STERIS (STE): Q4 Results Strong, Currency Woes Remain
Zacks Equity Research - Zacks Investment Research - Mon May 23, 8:28AM CDT
STERIS' (STE) segmental performance buoys optimism with growth witnessed across all four segments
BSX: 23.02 (-0.30), STE: 70.74 (-0.93), BAX: 44.49 (-0.26), LMAT: 15.03 (-0.06)

Boston Scientific's Full-Body MRI SCS System Gets FDA Nod
Zacks Equity Research - Zacks Investment Research - Fri May 20, 8:20AM CDT
Boston Scientific's (BSX) Precision Montage MRI SCS allows patients to undergo a full-body 1.5 Tesla MRI scan while also delivering multiple waveforms.
BSX: 23.02 (-0.30), SRDX: 23.19 (-0.11), BAX: 44.49 (-0.26), LMAT: 15.03 (-0.06)

LeMaitre Vascular to Participate in the Benchmark One-on-One Conference on June 2, 2016
GlobeNewswire - Wed May 18, 2:26PM CDT
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will participate in the Benchmark Company, LLC, One-on-One Investor Conference on Thursday, June 2, 2016 at the Pfister Hotel in Milwaukee, WI.
LMAT: 15.03 (-0.06)

Myriad Genetics: Test Revenues Strong, Currency Woes Stay
Zacks Equity Research - Zacks Investment Research - Mon May 16, 7:06AM CDT
Myriad (MYGN) ended the third quarter of fiscal 2016 on a promising note, beating the Zacks Consensus Estimate on both top and bottom-line fronts
BSX: 23.02 (-0.30), MYGN: 30.95 (-3.07), BAX: 44.49 (-0.26), LMAT: 15.03 (-0.06)

VWR Corp Posts Strong Q1 Results; Gross Margins Weak
Zacks Equity Research - Zacks Investment Research - Fri May 13, 6:48AM CDT
VWR Corp (VWR) started off 2016 on a promising note, with its first-quarter results beating the Zacks Consensus Estimate on both the top and the bottom-line fronts.
BSX: 23.02 (-0.30), VWR: 29.73 (-0.32), BAX: 44.49 (-0.26), LMAT: 15.03 (-0.06)

Illumina: Q1 Results Hit by Soaring Costs; '16 View Down
Zacks Equity Research - Zacks Investment Research - Thu May 12, 7:28AM CDT
Illumina (ILMN) made a disappointing start to first-quarter 2016 with its top and bottom lines lagging the Zacks Consensus Estimate.
SRDX: 23.19 (-0.11), BAX: 44.49 (-0.26), LMAT: 15.03 (-0.06), ILMN: 141.62 (-1.80)

Boston Scientific (BSX): Q1 Earnings Beat amid CRM Woes
Zacks Equity Research - Zacks Investment Research - Thu May 12, 7:18AM CDT
On May 11, 2016, we issued an updated research report on leading medical devices company, Boston Scientific Corporation (BSX). The stock currently carries a Zacks Rank #2 (Buy).
BSX: 23.02 (-0.30), LMAT: 15.03 (-0.06), NUVA: 58.98 (-1.03), OSUR: 7.78 (-0.13)

Phibro Animal (PAHC) Misses Q3 Earnings on Low Revenues
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:00AM CDT
Phibro (PAHC) ended the fiscal third quarter on a disappointing note, with its bottom line lagging the Zacks Consensus Estimate by a solid margin and its revenues failing to expand on a year-over-year basis.
SRDX: 23.19 (-0.11), PAHC: 19.28 (+0.01), BAX: 44.49 (-0.26), LMAT: 15.03 (-0.06)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Flooring Market to Hit $255 Billion by 2031: What's Driving This?

The Construction Wave Lifts Flooring High Feels like flooring is set to ride a massive wave in the construction boom—an ambitious $255.35 billion splash by 2031. It's not the kind of climb you see out of nowhere; it’s paved by a 4.17% CAGR from 2026. This growth screams opportunity for anyone knee-deep in the construction game, where every square inch needs flooring....

Cell Counting Market Growth: USD 17.71 Billion by 2031

The Cell Counting Surge: Money Talks in Science You can't deny it when the numbers speak—a jump from USD 12.39 billion to USD 17.71 billion by 2031 in the cell counting market means something ain't business as usual. That's a robust 7.40% CAGR folks; it's a field being bombarded with innovation. The spark? Automated and advanced cell analysis technology taking the...

Trimble Revamps SketchUp: Game-Changing Design Innovations

Breaking Down Trimble's Latest Moves in Design Software The design world spins on innovation, and Trimble's pushing the boat out with SketchUp 2027. Unveiled at the swanky Trimble Dimensions User Conference in Las Vegas, this revamp is all about smashing through workflow barriers that have tripped up designers for too long. If you've ever haggled with clunky model...

Call for Biotech Shift: Scarcity Drives Urgency

The Cry for an Industrial Biotech Shift Alright, folks, here's the deal: James Michael Matthew is waving a red flag. He's saying it's time to overhaul our approach to industrial biotechnology. Why? Because we're up against some big-time raw material shortages. Matthew's call isn't just a whisper in the wind; it's a siren echoing through an industry teetering on the edge...

Illinois's Able UP Redefines Disability Savings

A New Chapter for Disability Savings in Illinois Forget the PR gloss, folks—this is about putting more green in the pockets of folks who really need it. Illinois Treasurer Michael Frerichs is giving the state's disability savings program a serious makeover, rebranding it as Able UP and slicing the fees like a seasoned chef with a bad attitude. More Than Just a Name...

Innovative Sun Visor Tackles Trucking's Glare Issue

Shedding Light on Glare-Free Trucking Ever tried squinting your way down the highway with the sun blinding you through that annoying gap in your visor? Ask any trucker, and they'll tell you that battling glare isn't just about comfort, it's about staying safe and alert. Enter the new patent-pending invention out of Dallas that's here to address this gnawing issue—the...

Fields Law Firm Rallies for Toy Donations This Season

Community Spirit Kicks Off at Fields Law Firm It’s always a bright idea when companies open their doors for a good cause, especially when it involves spreading cheer to children. Over in Minnetonka, Fields Law Firm is doing just that as they jump into the holiday spirit by collecting toys for Toys for Tots through December 11. It’s a chance for everyone to get...

TIER IV Unveils Open-Source AI Models for Autonomous Cars

End-to-End AI: Revolution at TIER IV Well, folks, TIER IV is shaking things up in the world of autonomous driving. They've just rolled out a bunch of end-to-end (E2E) AI models under the open-source banner of Autoware. Each model is designed to adapt to different map and sensor setups. You know, it’s like they're handing the keys of customization to developers—whether...

Mather Promotes Connection with Free Gardening Kits

Winter Loneliness No Match for Mather’s Green Thumb Initiative Here's something heartfelt coming out of the Windy City: gardening kits. This ain't your standard Wall Street babble—it's about a nonprofit called Mather trying to shed some light on the colder months by giving seniors in Illinois a damn good reason to be joyfully busy. No boilersuit and tie needed, just a...

Otus Earns Top Spot in Education AI at Innovation Awards

Acknowledging AI's Growing Role in Education Times are changing, and the classroom ain't what it used to be. Enter Otus, a platform that's breaking the mold by bringing artificial intelligence smack dab into K-12 education. They've bagged the 2026 SmartBrief Innovation Award in AI within the Education category. Clocking in at serving nearly 100 school districts, it's...